Pricing Log in Create free account
Saturday 17 October 2026 Export GILD’s income statement to Excel — free account

Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS fell 638.2%, free cash flow grew 376.8% and total debt rose 5.21%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for ten consecutive years.

156.19 1.18 −0.75%
Market cap
$195.1B
P/E
0.0×
Fwd P/E
−46.2×
Dividend yield
2.08%
F-score
8/9
Altman Z
4.03
Beneish M
−2.45
Dividend safety
77/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Gilead Sciences, Inc. (GILD) Book value per share

Alert me on Book value per share

Gilead Sciences, Inc.'s book value per share at the end of fiscal 2025 was 18.2×, up 17.8% from 15.4× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 9.4×. Over the past ten years it has ranged from 13.1× (fiscal 2015) to 18.2× (fiscal 2023); the current reading is higher than 91% of that period. Gilead Sciences, Inc. ranks 13th of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 18.2× 17.80%
FY2024 15.4× (15.33%)
FY2023 18.2× 7.86%
FY2022 16.9× 0.77%
FY2021 16.8× 15.70%
FY2020 14.5× (18.72%)
FY2019 17.8× 7.50%
FY2018 16.6× 5.77%
FY2017 15.7× 8.47%
FY2016 14.5× 10.77%

Quarterly newest first

Period Book value per share Change
Jun 2026 9.4× (49.92%)
Mar 2026 18.9× 3.76%
Dec 2025 18.2× 5.33%
Sep 2025 17.3× 9.70%
42 more quarters

Against its own ten years

Low 13.1× High 18.2×
Ten-year median 16.6×
Current reading's percentile 91

Book value per share against peers

Company Book value per share
AZN AstraZeneca PLC compare 32.5×
NVS Novartis AG compare 22.0×
AMGN Amgen Inc. compare 21.6×
MRK Merck & Co., Inc. compare 17.0×
PFE Pfizer Inc. compare 15.0×
GSK GSK PLC Sponsored ADR compare 11.5×
BMY Bristol Myers Squibb Company compare 10.9×
GILD Gilead Sciences, Inc. 9.4×
NVO Novo Nordisk A/S compare 7.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on GILD